278 related articles for article (PubMed ID: 8138244)
1. Stimulation of phagocytic activity of murine Kupffer cells by tuftsin.
Kubo S; Rodriguez T; Roh MS; Oyedeji C; Romsdahl MM; Nishioka K
Hepatology; 1994 Apr; 19(4):1044-9. PubMed ID: 8138244
[TBL] [Abstract][Full Text] [Related]
2. Effect of tuftsin on human Kupffer cell.
Kubo S; Roh MS; Oyedeji C; Romsdahl MM; Nishioka K
Hepatogastroenterology; 1998; 45(24):2270-4. PubMed ID: 9951909
[TBL] [Abstract][Full Text] [Related]
3. Studies of human granulocyte phagocytosis stimulation by tuftsin.
Nishioka K; Wagle JR; Rodriguez T; Maeta M; Kubo S; Dessens SE
J Surg Res; 1994 Jan; 56(1):94-101. PubMed ID: 8277776
[TBL] [Abstract][Full Text] [Related]
4. Stability of sterile saline solutions of synthetic tuftsin, a naturally occurring immunomodulating peptide.
Nishioka K; Dessens SE; Rodriguez T
Pept Res; 1991; 4(4):230-3. PubMed ID: 1823602
[TBL] [Abstract][Full Text] [Related]
5. ADP-ribosylation of tuftsin suppresses its receptor-binding capacity and phagocytosis-stimulating activity to murine peritoneal macrophages.
Terashima M; Hara N; Badruzzaman M; Shimoyama M; Tsuchiya M
FEBS Lett; 1997 Jul; 412(1):227-32. PubMed ID: 9257725
[TBL] [Abstract][Full Text] [Related]
6. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and immunomodulatory activity of [60]fullerene-tuftsin conjugates.
Xu Y; Zhu J; Xiang K; Li Y; Sun R; Ma J; Sun H; Liu Y
Biomaterials; 2011 Dec; 32(36):9940-9. PubMed ID: 21937103
[TBL] [Abstract][Full Text] [Related]
8. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
Siemion IZ; Słoń J; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
[TBL] [Abstract][Full Text] [Related]
9. The evidence on the possible interleukin-1 alpha tuftsin competition.
Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
[TBL] [Abstract][Full Text] [Related]
10. [Tuftsin].
Mücke D
Allerg Immunol (Leipz); 1984; 30(3):127-38. PubMed ID: 6209973
[TBL] [Abstract][Full Text] [Related]
11. Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosis.
Bar-Shavit Z; Stabinsky Y; Fridkin M; Goldman R
J Cell Physiol; 1979 Jul; 100(1):55-62. PubMed ID: 381320
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated internalization of tuftsin by human polymorphonuclear leukocytes.
Amoscato AA; Davies PJ; Babcock GF; Nishioka K
J Reticuloendothel Soc; 1983 Jul; 34(1):53-67. PubMed ID: 6308252
[TBL] [Abstract][Full Text] [Related]
13. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
14. Calmodulin antagonists inhibit the phagocytic activity of cultured Kupffer cells.
Watanabe S; Hirose M; Miyazaki A; Tomono M; Takeuchi M; Kitamura T; Namihisa T
Lab Invest; 1988 Aug; 59(2):214-8. PubMed ID: 3404973
[TBL] [Abstract][Full Text] [Related]
15. Biochemical aspects of tuftsin deficiency syndrome.
Najjar VA
Med Biol; 1981 Jun; 59(3):134-8. PubMed ID: 6895538
[TBL] [Abstract][Full Text] [Related]
16. Substance P augmentation of CSF-1-stimulated in vitro myelopoiesis. A two-signal progenitor restricted, tuftsin-like effect.
Moore RN; Osmand AP; Dunn JA; Joshi JG; Rouse BT
J Immunol; 1988 Oct; 141(8):2699-703. PubMed ID: 2459223
[TBL] [Abstract][Full Text] [Related]
17. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
Paradowski A; Dynowski Z; Kubik A; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
[TBL] [Abstract][Full Text] [Related]
18. Effects of macrophage colony-stimulating factor on the proliferation and the function of Kupffer cells.
Urano F; Imoto M; Fukuda Y; Koyama K; Nakano I
Arzneimittelforschung; 1993 Jul; 43(7):804-7. PubMed ID: 8369016
[TBL] [Abstract][Full Text] [Related]
19. Methyl palmitate: inhibitor of phagocytosis in primary rat Kupffer cells.
Cai P; Kaphalia BS; Ansari GA
Toxicology; 2005 Jun; 210(2-3):197-204. PubMed ID: 15840433
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms.
Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM
J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
